LONDON, Nov 16 (Reuters) - Britain said it was in advanced
talks to access an experimental COVID-19 vaccine developed by
Moderna Inc, which interim data on Monday indicated was
94.5% effective.
"As part of the ongoing work of the Vaccines Taskforce, the
government is in advanced discussions with Moderna to ensure UK
access to their vaccine as part of the wider UK portfolio," a
government spokesperson said.
"Moderna are currently scaling up their European supply
chain which means these doses would become available in spring
2021 in the UK at the earliest."
(Reporting by Paul Sandle; Editing by Kate Holton)